Late-Breaking Analysis In Hypertension Shows That Antihypertensive Treatments Differ In Their Ability To Preserve Lives

STOCKHOLM, August 30, 2010 /PRNewswire/ -- According to the results of a late-breaking analysis...

Clinical Results For New Treatment Of Bacterial Vaginosis Infection

The Swedish company Laccure AB recently got CE marking as a Class IIa medical device product for...

88 Percent Of UK Doctors Believe Whiplash Claims Are Exaggerated

AXA, a UK car insurer, has surveyed UK doctors as part of its ongoing campaign to understand the...

On Facebook, Women Are More Plentiful But Men Are Better Ad Targets

Global digital marketing companies Resolution Media and Kenshoo Social published a new report today...

User picture.
Anna OhldenRSS Feed of this column.

Media Relations Executive, PR Newswire Europe... Read More »


LONDON, December 7 /PRNewswire/ -- David Brennan, AstraZeneca CEO, and senior management from AstraZeneca (LSE: AZN) (NYSE: AZN) and MedImmune discuss opportunities in the biologics field, R&D and portfolio progress plus the Group's current focus and priorities. Video interviews and transcripts are available now on

It's free to view. All you need to do is register at is an online financial website featuring in-depth interviews, documentaries and webcasts with senior company executives addressing the critical issues facing their businesses. If you would like to contact us, please email or phone +44-207-936-1333.

DUSSELDORF, Germany, December 7 /PRNewswire/ -- The Kythera Award, founded in 2001 by the author and artist Gabriele Henkel, is awarded annually to particularly deserving artists with respect to cultural exchange between Germany and the Latin countries of Europe. The former recipients are publisher Klaus Wagenbach, film director Patrice Chéreau, conductor Claudio Abbado, architect Renzo Piano as well as art historian Dr. Sylvia Ferino in the K.H.M. in Vienna.

RIO DE JANEIRO, Brazil and AMSTERDAM, December 7 /PRNewswire/ -- Petrobras and Avantium announced today that they have started a research collaboration for the development of new catalysts for emerging technologies within Petrobras, Brazil's largest energy company.

Avantium specializes in experimental methodologies that enable scientists to conduct parallel experiments on a very small scale and at a very high speed. This increases productivity and allows scientists to explore and compare very large numbers of experimental conditions and catalytic materials. Statistical techniques are applied to direct the experimental program into the most promising areas and to extract knowledge from the data that can be used to optimize industrial processes.

BERLIN, December 7 /PRNewswire/ --

CONNECTIONS(TM) Europe has finished following three full days of interactive panels with top international executives discussing new business models and growth opportunities in the digital living markets.

Parks Associates, in partnership with CEA(R), hosted CONNECTIONS(TM) Europe on December 4-6, 2007, at the Adlon Kempinski, Berlin, Germany. Sponsors included IBM, io-homecontrol, Radialpoint, AwoX, Casero Inc., Design of Systems on Silicon, Intamac Systems Ltd, Invest in Germany, NDS, Netineo, NXP Semiconductors, SiConnect, Thomson, Yitran Communications Ltd., Zensys Inc., Macrovision, SmartLabs, Inc., Smart Design, and Universal Electronics.